Assistant Professor Ni Qianqian
B.Med., Nanjing University (Clinical Medicine)
PhD., Nanjing University (Medical Imaging and Nuclear medicine)
Postdoctoral Fellow, National Institutes of Health (Molecular Imaging and Nanomedicine)
Dr Ni received her B.Med and PhD in an 8-year medicine program from Nanjing University. After postdoc training in NIBIB/NIH, Dr Ni joined NUS and started her Assistant Professorship in 2021. Dr. Ni’s research over the past five years focused on applying advances in nanotechnology to improve cancer immunotheranostics: 1) novel cancer nanovaccines for cancer immunotherapy; 2) novel nucleic acid nanomedicine for cancer theranostics and cancer immunomodulations. The PI’s main clinical direction is the use of advanced CT, MRI angiography techniques, image post-processing, and artificial intelligence for the diagnosis of cardiovascular disorders and thoracic diseases.
Zhang Miao graduated from Peking University in 2010, where he obtained his B.Sc. in Pharmacy and M.Sc. in Pharmaceutical Sciences. He then worked as senior formulation scientist in the R&D department of Pfizer pharmaceutical company. In 2023, he obtained his Ph.D. Degree in National University of Singapore focusing on nanotechnology for cancer chemotherapy and gene therapy. He joined Dr. Ni’s lab in Mar. 2023, where he works on nanovaccine and immunotherapy for cancer treatment.
Haijun joined Dr. Ni's lab in Jan. 2024, where he works on mRNA vaccine for cancer treatment. Before joining NUS, he was a postdoctoral scholar at Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences from 2021 to 2024. He received the PhD degree from Shanghai Center for Excellence in Molecular Cell Science, Chinese Academy of Sciences in 2020, the M.Sc. degree from Kunming Institute of Botany, Chinese Academy of Sciences in 2015, and the B.Sc. degree from Nanchang University in 2008.
Visiting Research Fellow
Bingyu graduated from Tongji University in 2018, where he obtained his B.Sc. and Ph.D.in Biology. His research is focused on the drug delivery of cancer immunotherapy. He joined Dr. Ni's lab to study mRNA-based Immunotherapeutics design and its drug delivery for cancer immunotherapy.
Yongling obtained his PhD. Degree from Shanghai University of Traditional Chinese Medicine, Shanghai, China. Currently, he works as Clinical Pharmacist, Pharmacy Department, Affiliated Hospital of Zunyi Medical University, Zunyi, China. He joined Dr. Ni's lab as visiting scholar to study nanomedicine design and its drug delivery for cancer immunotherapy.
Shengqi graduated from University of Science and Technology of China in 2016, where he obtained Ph. D. degree and Bachelor’s degree in polymer chemistry and physics. He then worked as an associate research fellow in Anhui University of Chinese Medicine focusing on nano formulations of Chinese medicine for cancer therapy. He joined in Dr. Ni’s lab in Jan. 2024, where he works on nanomedicine for cancer therapy via vascular mediation.
Ong Yen Hui
Yen Hui graduated from University of Tunku Abdul Rahman, Malaysia, where she obtained her B.Sc. (Honours) in Biomedical Science (2014) and M.Sc. in Molecular Biology (2019). Her current work in Dr Ni's lab is focusing on cancer immunology, particularly mRNA nanomedicine-based gene therapy.
Xiaolin graduated from Nanjing University of Posts & Telecommunications in 2023, where he obtained his M.Sc. in Electronic Information, and graduated from Tianjin University in 2020, where he obtained his B.Sc. in Materials Science and Engineering. He has worked on synthesis of hierarchical gols nanoparticles. He joined Dr. Ni's lab to work on nasal delivery of lipid nanoparticle-mRNA vaccine.